<DOC>
	<DOCNO>NCT02861196</DOCNO>
	<brief_summary>This research aim explore therapeutic effect neoadjuvant chemotherapy muscular invasive bladder cancer T2-4aN0M0 , survival effect combined-modality treatment model，then clarify probability bladder preservation , correspond cancer specific survival , quality life .</brief_summary>
	<brief_title>Research Combined-Modality Treatment Model Bladder Preservation Muscular Invasive Bladder Cancer</brief_title>
	<detailed_description />
	<mesh_term>Urinary Bladder Neoplasms</mesh_term>
	<criteria>1. bladder urothelium carcinoma 2. cT24aN0M0 3. life expectancy≥1 year 4 . ECOG PS 01 5. previously receive radiotherapy chemotherapy 6. major organ dysfunction 7. provide inform write consent 1. extensive carcinoma situ ureter invade 2. distant metastasis primary diagnosis lymphatic metastasis accord clinical diagnosis 3. severe major organ dysfunction 4. finish treatment severe disease life expectance≤6 month 5. exist malignant tumor 6. severe coagulation disorder 7. trail participate 4 week</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>